US Patent 7608626 Substituted indolizines and derivatives as CNS agents
Patent 7608626 was granted and assigned to Wyeth on October, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Annmarie Louise Sabb0
Robert Lewis Vogel0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+96 characters)
Article
Patent abstract
Compounds of formula 1 or pharmaceutically acceptable salts thereof are provided:
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07608626 Substituted indolizines and derivatives as CNS agents US Patent 7608626 Substituted indolizines and derivatives as CNS agents
Infobox
Patent Number
07608626
Patent Number
7608626
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07608626 Substituted indolizines and derivatives as CNS agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07608626
Date of patent
October 27, 2009
Patent application number
11260716
Date Filed
October 27, 2005
Patent primary examiner
Find more entities like US Patent 7608626 Substituted indolizines and derivatives as CNS agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
